tiprankstipranks
Trending News
More News >
Epigenomics (DE:ECX)
FRANKFURT:ECX
Germany Market

Epigenomics (ECX) Cash flow

Compare
1 Followers

Epigenomics Cash Flow

DE:ECX's free cash flow for Q3 2022 was $-2.66M. For the 2022 fiscal year, DE:ECX's free cash flow was decreased by $5.41M and operating cash flow was $-2.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -4.15M$ -9.57M$ -13.51M$ -10.35M$ -9.58M
Investing Cash Flow
$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow
$ ―$ ―$ ―$ ―$ ―
End Cash Position
$ ―$ ―$ ―$ ―$ ―
Free Cash Flow
$ -4.19M$ -9.59M$ -13.63M$ -10.46M$ -10.16M
Currency in USD

Epigenomics Cash Flow